Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Infection

Treating recurrent C. difficile infection—the challenge continues

Nature Reviews Gastroenterology & Hepatology volume 10, pages 10–11 (2013)Cite this article

Subjects

Treatment of recurrent Clostridium difficile infection is challenging. New research now replicates human disease in a mouse model, shedding light on why antibiotics often fail to prevent further recurrences and demonstrating that targeted manipulation of the gut microbiota could be a feasible treatment option.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Lawley, T. D. et al. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog. 8, e1002995 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Surawicz, C. M. et al. The search for a better treatment for recurrent Clostridium difficile disease: the use of high dose vancomycin combined with Saccharomyces boulardii. Clin. Infect. Dis. 31, 1012–1017 (2000).

    Article  CAS  PubMed  Google Scholar 

  3. Chang, J. Y. et al. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J. Infect. Dis. 197, 435–438 (2008).

    Article  PubMed  Google Scholar 

  4. Gough, E., Shaikh, H. & Manges, A. R. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin. Infect. Dis. 53, 994–1002 (2011).

    Article  PubMed  Google Scholar 

  5. Tvede, M. & Rask-Madsen, J. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet 1, 1156–1160 (1989).

    Article  CAS  PubMed  Google Scholar 

  6. Allen-Vercoe, E. A Canadian Working Group report on fecal microbiota therapy: microbial ecosystems therapeutics. Can. J. Gastroenterol. 26, 457–462 (2012).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Department of Medicine, University of Washington School of Medicine, 325 Ninth Avenue, Box 359773, Seattle, 98104, WA, USA

    Christina M. Surawicz

Authors
  1. Christina M. Surawicz
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Surawicz, C. Treating recurrent C. difficile infection—the challenge continues. Nat Rev Gastroenterol Hepatol 10, 10–11 (2013). https://doi.org/10.1038/nrgastro.2012.240

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrgastro.2012.240

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing